drugset / Trial / NCT06688123
Efficacy and Safety of SHR-3167 and Insulin Glargine in Type 2 Diabetes Subjects
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of SHR-3167 compared with insulin glargine after treatment in insulin naïve subjects with type 2 diabetes treated with metformin alone or in combination with SGLT2 subjects.
Timeline
- Start
- 2025-01-08
- Primary completion
- 2026-04-22
- Completion
- 2026-04-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SHR-3167 | Unknown | — | — |
| Comparator | insulin glargine | Protein / enzyme biologic | — | — |